Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia (HPP) in Children and Adults in Russia

NCT07390240 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07390240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07390240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia (HPP) in Children and Adults in Russia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
December 29, 2025
Completion date
June 30, 2030
Enrollment
55 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypophosphatasia